Serum Institute places India trials of AstraZeneca’s COVID-19 vaccine on maintain


Mumbai, September 10

Serum Institute of India has put trials of AstraZeneca’s COVID-19 vaccine candidate on maintain till the British drugmaker restarts the trials, Serum stated on Thursday.

“We are reviewing the situation and pausing India trials,” Serum stated in a quick assertion.

AstraZeneca stated on Tuesday it had paused trials of its experimental coronavirus vaccine due to an unexplained sickness in a examine participant, however its associate Serum had on the time stated its trials in India have been nonetheless ongoing. Reuters 



Be the first to comment on "Serum Institute places India trials of AstraZeneca’s COVID-19 vaccine on maintain"

Leave a comment

Your email address will not be published.


*


%d bloggers like this: